JP Morgan Chase
GMED icon

JP Morgan Chase’s Globus Medical GMED Stock Holding History

JP Morgan Chase’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,300
Closed -$647K – 7553
2025
Q3 		$647K Hold
11,300
– – ﹤0.01% 4874
2025
Q2 		$667K Buy
+11,300
New +$730K ﹤0.01% 4627

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase's GMED Position: Q1 2026 in Review

JP Morgan Chase reduced its Globus Medical (GMED) stake by 16% in Q1 2026, selling an estimated $45.2M and leaving 2,595,308 shares worth $217M. The position accounts for 0.01% of the portfolio, ranked #663.

JP Morgan Chase first reported a position in GMED in Q3 2013 and has held it in 47 quarters since. The position peaked at $271M in Q4 2025. 603 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • JP Morgan Chase held 2,595,308 shares of Globus Medical worth $217M as of Q1 2026.
  • JP Morgan Chase sold 503,465 Globus Medical shares in Q1 2026, an estimated $45.2M.
  • Globus Medical made up 0.01% of JP Morgan Chase's portfolio in Q1 2026, its #663 holding.
  • JP Morgan Chase first reported a position in Globus Medical in Q3 2013 and has held it in 47 quarters since.
  • JP Morgan Chase's Globus Medical position peaked at $271M in Q4 2025.
  • 603 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.